We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+0.18%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$510M
AUM Growth
-$913K
Cap. Flow
+$9.23M
Cap. Flow %
1.81%
Top 10 Hldgs %
43.53%
Holding
86
New
2
Increased
32
Reduced
18
Closed
4

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$2.21M
2
ADBE icon
Adobe
ADBE
+$2.06M
3
BALL icon
Ball Corp
BALL
+$1.53M
4
NVDA icon
NVIDIA
NVDA
+$1.14M
5
MRNA icon
Moderna
MRNA
+$1M

Sector Composition

Rank Sector Weight
1 Technology 32.6%
2 Healthcare 16.34%
3 Industrials 11.65%
4 Consumer Discretionary 9.44%
5 Communication Services 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRNA icon
76
Moderna
MRNA
$23.6B
-15,000
Closed -$1M

Similar funds

Brian C. Broderick's Q4 2024 Portfolio in Review

As of Q4 2024, Brian C. Broderick held 86 positions worth $510M, down 0.18% from $511M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Brian C. Broderick's Q4 2024 filing shows 2 new, 32 increased, 18 reduced and 4 closed positions. Its largest new stake was Salesforce: 6,764 shares worth $2.26M. The largest sale was Medtronic, an estimated $2.21M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.

  • Brian C. Broderick's largest Q4 2024 buy was Salesforce: 6,764 shares worth $2.26M.
  • Brian C. Broderick added most to Vertex Pharmaceuticals in Q4 2024, an estimated $2.51M increase.
  • Brian C. Broderick's biggest Q4 2024 reduction was Medtronic, cutting an estimated $2.21M.
  • Brian C. Broderick fully exited Moderna in Q4 2024, selling an estimated $1M.
  • Brian C. Broderick's ten largest holdings make up 44% of its $510M portfolio in Q4 2024.
  • Brian C. Broderick opened 2 new positions and closed 4 in Q4 2024.
  • Brian C. Broderick's portfolio value fell 0.18% quarter-over-quarter to $510M.

Based on Brian C. Broderick's 13F filing for Q4 2024, filed 13 Feb 2025.